SCHEMBL18557136

SCHEMBL18557136

Clc1nc(NC2CCCCCCCC2)nc(-c2ccccn2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR39 O43194 2/20 0.56
KDM4E B2RXH2 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
LMNA P02545 1/20 0.52
HSP90AA1 P07900 1/20 0.52
SLC2A1 P11166 1/20 0.52
HTT P42858 1/20 0.52
KMT2A Q03164 1/20 0.52
NCOA1 Q15788 1/20 0.52
NCOA3 Q9Y6Q9 1/20 0.52
GAA P10253 2/20 0.50
PDE4A P27815 1/20 0.50
TRPM8 Q7Z2W7 2/20 0.49
FLT3 P36888 2/20 0.49
TYRO3 Q06418 2/20 0.49
MERTK Q12866 2/20 0.49
GAS6 Q14393 2/20 0.49
AXL P30530 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21573363 1.00 GPR39 (0.56) GPR39KDM4ENPSR1SMN1; SMN2TDP1
SCHEMBL20402919 1.00 GPR39 (0.56) GPR39KDM4ENPSR1SMN1; SMN2TDP1
SCHEMBL19240855 0.81 PDE4A (0.55) KDM4ESMN1; SMN2PDE4ARAB9AMAPT
SCHEMBL15131535 0.78 IDH1 (0.64) PDE4ARAB9AIDH1IDH2
SCHEMBL17971630 0.76 METAP1 (0.56) GPR39KDM4ESMN1; SMN2TDP1LMNA
SCHEMBL29763317 0.75 TDP1 (0.51) KDM4ESMN1; SMN2TDP1LMNAHTT
SCHEMBL15102645 0.75 TDP1 (0.51) KDM4ESMN1; SMN2TDP1LMNAHTT
SCHEMBL29763352 0.75 MAPK14 (0.46) GPR39TRPM8FLT3TYRO3MERTK
SCHEMBL15102280 0.75 MAPK14 (0.46) GPR39TRPM8FLT3TYRO3MERTK
SCHEMBL15094872 0.75 GBA1 (0.54) KDM4ENPSR1SMN1; SMN2LMNAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9579324-B2 Therapeutically active compounds and their methods of use AGIOS PHARMACEUTICALS, INC (US) 2017-02-28 US disclosed